产品详情
简单介绍：
Anti-Phospho-Paxillin(Ser178)抗体产品质量稳定，实验效果明显，货期快，价格优惠，欢迎垂询订购！我公司长期供应**组化抗体、WB抗体、**组化试剂盒和抗体试验所需全部相关试剂、荧光标记抗体、单克隆抗体、多克隆抗体、各种标记的二抗IgG/IgM/IgD/IgA等科研实验抗体。Anti-Phospho-Paxillin(Ser178)抗体用于**组化实验,WB实验,相应的标记抗体有HRP标记抗体,FITC标记,BIO等。
详情介绍：
Rabbit Anti-Phospho-Paxillin(Ser178)
Cat. Number:
Anti-Phospho-Paxillin(Ser178)抗体KL-5550R
Quantity size:
0.1ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Paxillin is a 64 kDa cytoskeletal adapter protein involved in organisation and function of focal adhesions, which are critical to cell adhesion and migration. This in turn plays a role in a wide variety of processes including embryogenesis, organogenesis, wound repair, inflammation and cancer. Paxillin contains LD motifs,
Anti-Phospho-Paxillin(Ser178)抗体LIM domains, SH3 and SH2 binding domains that serve as docking sites for cytoskeletal proteins, tyrosine kinases (e.g., FAK, Pyk 2, Src), serine/threonine kinases, GTPase activating proteins and other adaptor proteins (e.g., Actin, Vinculin, Crk).
Also known as:
PXN(phospho S178); Paxillin (phospho S178); Paxillin (phospho Ser178); p-Paxillin (Ser178); Paired box protein Pax 1; PAX 1;
Anti-Phospho-Paxillin(Ser178)抗体PAX1; Paxillin alpha; PXN; PXN protein; FLJ16691; FLJ23042; FLJ16691; PAXI_HUMAN; Paxillin; PXN protein.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, .
●
Immunogen: KLH conjugated
Anti-Phospho-Paxillin(Ser178)抗体Synthesised phosphopeptide derived from human Paxillin around the phosphorylation site of Ser178.
●
Predicted Molecular Weight: 65kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-Phospho-Paxillin(Ser178)抗体
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-Phospho-Paxillin(Ser178)抗体
Optimal working dilutions must be determined by the end user.
